Related Experiment Video
Updated: Sep 13, 2025

15:48
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
9.7K
ADEM as an Initial Presentation of SLE: A Case Report
Yousuf Sherwani1,2,3, Ayham Alsaab1, Mohan Sengodan1
1Medical City Arlington Hospital, Arlington, TX 76015, USA.
Reports (MDPI)
|July 29, 2025
Summary
Acute disseminated encephalomyelitis (ADEM), an immune-mediated brain disorder, can be linked to autoimmune conditions. This case study shows successful treatment of ADEM in a lupus patient using corticosteroids and rituximab.
Area of Science:
- Neuroimmunology
- Autoimmune Diseases
Background:
- Acute disseminated encephalomyelitis (ADEM) is an inflammatory demyelinating disorder of the central nervous system's white matter.
- The pathophysiology of ADEM is primarily considered immune-mediated, often triggered by infections or other incidents.
- Emerging research suggests a potential association between ADEM and underlying autoimmune conditions.
Observation:
- This report details a case of ADEM in a middle-aged woman.
- The patient was diagnosed with systemic lupus erythematosus (SLE), an autoimmune disease.
- The presentation involved ADEM occurring in the context of known SLE.
Findings:
- The patient with ADEM and SLE demonstrated a positive response to treatment.
- Therapeutic interventions included corticosteroids and rituximab.
- Successful recovery was observed following this treatment regimen.
Implications:
- This case highlights the potential link between ADEM and autoimmune diseases like SLE.
- It suggests that corticosteroids and rituximab are effective treatment options for ADEM in patients with autoimmune conditions.
- Further research into the autoimmune basis of ADEM may reveal new therapeutic strategies.

